根据财联社的报道，埃隆·马斯克旗下的脑机接口公司Neuralink近日宣布，他们已经成功地为第二位人类患者植入了脑机接口芯片。这一进展标志着Neuralink在脑机接口技术领域的又一重要里程碑。
在访谈中，马斯克透露，第二颗植入物的进展似乎非常顺利。他表示，Neuralink计划在一周左右的时间内将其设备植入第二位人类患者体内。此次植入是Neuralink的PRIME研究的一部分，该研究旨在帮助因脊髓损伤或肌萎缩性侧索硬化症（ALS）导致四肢瘫痪的患者通过意念控制外部设备。
Neuralink的植入物使用了1024个电极，旨在帮助患者恢复部分身体功能。马斯克没有透露第二名被植入者的详细信息，只是表示这名参与者的脊髓损伤情况与第一名患者相似。他表示，植入第二名患者大脑的400个电极正在工作，并且进展顺利。
此外，马斯克还透露，他已经与前总统特朗普进行了交谈，讨论组建一个旨在通过减少商业监管来提高“政府效率”的委员会。马斯克表示，他愿意参与这个委员会，并认为美国的监管阻碍了创新。
Neuralink计划在今年内为另外8名患者进行植入，作为其临床试验的一部分。第一位接受植入手术的患者诺兰·阿博表示，手术后他现在只需思考就能控制电脑屏幕，这给了他一点独立性，减少了他对护理人员的依赖。不过，他也遇到了植入物细导线缩回的问题，但Neuralink的高管们表示，通过修改算法使设备感应更敏感，他们已经恢复了植入物监测大脑信号的能力。
这一系列进展显示了Neuralink在脑机接口技术方面的持续进步，以及马斯克对于推动人类科技发展的决心。随着研究的深入，未来这一技术有望为更多患者带来福音。
英语如下：
News Title: “Neuralink Breaks Records Again: Second Human Patient Successfully Implanted with Brain-Machine Interface”
Keywords: Implantation, Progress, Musk
News Content: According to a report by Caixin, Elon Musk’s brain-machine interface company, Neuralink, recently announced that they have successfully implanted a brain-machine interface chip in the second human patient. This advancement marks another significant milestone for Neuralink in the field of brain-machine interface technology.
In an interview, Musk revealed that the progress of the second implantation seems to be going very smoothly. He stated that Neuralink plans to implant its device into the second human patient’s body within a week. This implantation is part of the PRIME study, which aims to help patients who have suffered from quadriplegia due to spinal cord injuries or amyotrophic lateral sclerosis (ALS) to control external devices through thought.
Neuralink’s implant uses 1024 electrodes aimed at helping patients regain some physical functions. Musk did not disclose the detailed information of the second implantee, only stating that the participant’s spinal cord injury was similar to that of the first patient. He mentioned that the 400 electrodes implanted in the second patient’s brain are currently working and progressing smoothly.
Additionally, Musk revealed that he has had discussions with former President Trump about forming a committee aimed at increasing “government efficiency” by reducing commercial regulations. Musk expressed his willingness to participate in this committee and believed that the regulations in the United States hinder innovation.
Neuralink plans to implant its device in eight more patients this year as part of its clinical trial. The first patient to undergo the implantation surgery, Nolan Arno, stated that after the surgery, he can now control the computer screen with just a thought, giving him a bit of independence and reducing his dependency on caregivers. However, he encountered a problem with the fine wires of the implant retracting, but Neuralink’s executives stated that by modifying the algorithm to make the device more sensitive, they have restored the ability to monitor brain signals from the implant.
These series of advancements show the continuous progress of Neuralink in the field of brain-machine interface technology and Musk’s determination to push forward human technological development. As the research deepens, this technology is expected to bring hope to more patients in the future.
【来源】https://www.cls.cn/detail/1753862
Views: 2